Back to top
more

Lannett Co Inc (LCI)

(Delayed Data from NYSE)

$8.54 USD

8.54
1,487,457

+0.70 (8.93%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.54 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Bausch (BHC) Beats on Q3 Earnings & Sales, Raises Guidance

by Zacks Equity Research

Bausch (BHC) beats on sales and earnings in the third quarter and raises annual guidance.

Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y

by Zacks Equity Research

Endo (ENDP) reports better-than-expected results for the third quarter as Xiaflex delivers a strong performance.

Lannett (LCI) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Lannett (LCI) closed at $11.88, marking a -1% move from the previous day.

Analysts Estimate Lannett (LCI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lannett (LCI) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Lannet's (LCI) fiscal first-quarter 2020 results are likely to reflect strong performance of its anti-psychosis and cardiovascular drugs.

    Lannett (LCI) Outpaces Stock Market Gains: What You Should Know

    by Zacks Equity Research

    Lannett (LCI) closed the most recent trading day at $12.26, moving +1.16% from the previous trading session.

    Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (LCI) Outperforming Other Medical Stocks This Year?

    Lannett (LCI) Dips More Than Broader Markets: What You Should Know

    by Zacks Equity Research

    Lannett (LCI) closed at $11.73 in the latest trading session, marking a -1.84% move from the prior day.

    The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet

    Buy These 5 Defensive Stocks to Counter Market Volatility

    by Zacks Equity Research

    Markets have turned volatile due to poor economic data and geopolitical tensions, here are five defensive stocks to boost your portfolio.

    Lannett (LCI) Stock Moves -0.9%: What You Should Know

    by Zacks Equity Research

    Lannett (LCI) closed at $12.18 in the latest trading session, marking a -0.9% move from the prior day.

    Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (LCI) Outperforming Other Medical Stocks This Year?

    Top Ranked Momentum Stocks to Buy for October 1st

    by Zacks Equity Research

    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 1st

    Will Lannett Continue to Surge Higher?

    by Zacks Equity Research

    As of late, it has definitely been a great time to be an investor Lannett Company.

    Lannett (LCI) is a Great Momentum Stock: Should You Buy?

    by Zacks Equity Research

    Does Lannett (LCI) have what it takes to be a top stock pick for momentum investors? Let's find out.

    Top Ranked Momentum Stocks to Buy for September 19th

    by Zacks Equity Research

    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 19th

    Moving Average Crossover Alert: Lannett Company

    by Zacks Equity Research

    Lannett Company is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

    Ardelyx (ARDX) in Focus: Stock Moves 8.3% Higher

    by Zacks Equity Research

    Ardelyx (ARDX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

    Kinjel Shah headshot

    Small Drug Stock Outlook: Innovation Holds the Key to Growth

    by Kinjel Shah

    Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity have kept small drugmakers afloat in a competitive market.

    Lannett (LCI) Hits 52-Week High, Can the Run Continue?

    by Zacks Equity Research

    Lannett (LCI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Is the Options Market Predicting a Spike in Lannett (LCI) Stock?

    by Zacks Equity Research

    Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

    Ensign Group to Spin Off Home Health & Hospice Business

    by Zacks Equity Research

    Ensign Group (ENSG) to separate its home health and hospice business from the parent company.

    Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Adds 6% in Session

    by Zacks Equity Research

    Catalyst Pharmaceuticals (CPRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

    Lannett (LCI) Tops Q4 Earnings and Revenue Estimates

    by Zacks Equity Research

    Lannett (LCI) delivered earnings and revenue surprises of 76.19% and 9.68%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

    Earnings Preview: Lannett (LCI) Q4 Earnings Expected to Decline

    by Zacks Equity Research

    Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.